Abstract
Atherothrombosis is the leading cause of death in western countries. Major complications of atherothrombotic disease, which are responsible for a large burden of morbidity and mortality, are acute coronary syndromes, ischemic stroke, and peripheral occlusive disease. Plaque rupture, platelet adhesion, aggregation, and thrombosis may lead to unstable angina and may progress to myocardial infarction as well as to ischemic stroke. Platelet membrane glycoprotein receptors mediate crucial reactions in acute thrombosis and chronic processes of atherogenesis. The platelet glycoprotein GP IIb/IIIa, which is the most abundant platelet receptor, also represents the drug target of a novel class of anti-platelet drugs, which includes abciximab, tirofiban, and eptifibatide. The genes encoding the three major platelet glycoprotein receptors (GP Ib/IX/V, GP Ia/IIa, and GP IIb/IIIa) are subject to considerable genetic variability. This paper reviews how polymorphisms in the platelet glycoprotein receptors affect platelet function, susceptibility to atherothrombosis and its major complications including myocardial infarction, stroke, and complications following percutaneous coronary interventions, and individual variability of drug response. Recent data on platelet glycoprotein receptor polymorphisms as modifiers of drug action and as predictors of drug response offer the perspective of individualized drug treatment. Prospective studies will show whether this approach is useful or not. As the data reviewed here show clearly, future clinical trials should routinely take into account genetic susceptibility factors and modifiers, both for study design and for predefined patient stratification.
Similar content being viewed by others
Abbreviations
- ACS:
-
Acute coronary syndrome
- CI:
-
Confidence interval
- DCA:
-
Directional coronary atherectomy
- GP:
-
Glycoprotein
- MACE:
-
Major adverse cardiac event
- MI:
-
Myocardial infarction
- PCI:
-
Percutaneous coronary intervention
- PTCA:
-
Percutaneous transluminal coronary angioplasty
- RR:
-
Relative risk
- SCD:
-
Sudden cardiac death
- VWF:
-
Von Willebrand factor
References
Abbate R, Marcucci R, Camacho-Vanegas O, Pepe G, Gori AM, Capanni M, Simonetti I, Prisco D, Gensini GF (1998) Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 82:524–525
Afshar Kharghan V, Li CQ, Khoshnevis Asl M, Lopez JA (1999) Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 94:186–191
Aleksic N, Juneja H, Folsom AR, Ahn C, Boerwinkle E, Chambless LE, Wu KK (2000) Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 102:1901–1905
Anderson JL, King GJ, Bair RL, Elmer SP, Muhlestein JB, Habashi J, Carlquist JF (1999) Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 33:727–733
Andrews R, Shen Y, Gardiner E, Dong J, Lopez J, Berndt M (1999) The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost 82:357–364
Andrioli G, Minuz P, Solero P, Pincelli S, Ortolani R, Lussignoli S, Bellavite P (2000) Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa). Br J Haematol 110:911–918
Ardissino D, Mannucci, PM, Merlini PA, Duca F, Fetiveau R, Tagliabue L, Tubaro M, Galvani M, Ottani F, Ferrario M, Corral J, Margaglione M (1999) Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 94:46–51
Atherosclerosis, Thrombosis and Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107:1117–1122
Baker RI, Eikelboom J, Lofthouse E, Staples N, Afshar-Kharghan V, Lopez JA, Shen Y, Berndt MC, Hankey G (2001) Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 98:36–40
Benze G, Heinrich J, Schulte H, Rust S, Nowak-Gottl U, Tataru MC, Kohler E, Assmann G, Junker R (2002) Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J 23:325–330
Boden WE, McKay RG (2001) Optimal treatment of acute coronary syndromes—an evolving strategy. N Engl J Med 344:1939–1942
Bottiger C, Kastrati A, Koch W, Mehilli J, Seidl H, Schomig K, von Beckerath N, Schomig A (2000) HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 83:559–562
Boudoulas KD, Cooke GE, Roos CM, Bay PF, Goldschmidt-Clermont (2001) The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Arch Pathol Lab Med 125:112–115
Bray PF, Barsh G, Rosa JP, Luo XY, Magenis E, Shuman MA (1988) Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa. Proc Natl Acad Sci USA 85:8683–8687
Cadroy Y, Sakariassen KS, Charlet JP, Thalamas C, Boneu B, Sie P (2001) Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood 98:3159–3161
Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A (1999) The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood 93:3583–3586
Carter AM, Ossei-Gerning G, Grant PJ (1996) Platelet glycoprotein IIIa PlA polymorphism in young men with myocardial infarction. Lancet 348:485–486
Carter AM, Catto AJ, Bamford JM, Grant PJ (1998) Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol 18:1124–1131
Casorelli I, De Stefano V, Leone AM, Chiusolo P, Burzotta F, Paciaroni K, Rossi E, Andreotti F, Leone G, Maseri A (2001) The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol 114:150–15
Coller BS (1995) Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation 92:2373–2380
Coller BS (1997) Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest 99:1467–1471
Corral J, Gonzalez-Conejero R, Rivera J, Iniesta JA, Lozano ML, Vicente V (1997) HPA-1 genotype in arterial thrombosis—role of HPA-1b polymorphism in platelet function. Blood Coagul Fibrinolysis 8:284–290
Corral J, Lozano ML, Gonzalez-Conejero R, Martinez C, Iniesta JA, Rivera J, Vicente V (2000) A common polymorphism flanking the ATG initiator codon of GPIb alpha does not affect expression and is not a major risk factor for arterial thrombosis. Thromb Haemost 83:23–28
Croft SA, Hampton KK, Sorrell JA, Steeds RP, Channer KS, Samani NJ, Daly ME (1999) The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction. Br J Haematol 106:771–776
Di Paola J, Federici AB, Mannucci PM, Canciani MT, Krtizik M, Kunicki TJ, Nugent D (1999) Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 93:3578–3582
Douglas H, Michaelides K, Gorog DA, Durante-Mangoni E, Ahmed N, Davies GJ, Tuddenham EG (2002) Platelet membrane glycoprotein Ibalpha gene—5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis. Heart 87:70–74
Durante-Mangoni E, Davies GJ, Ahmed N, Ruggiero G, Tuddenham EG (1998) Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism. Thromb Haemost 80:218–219
Feng D, Lindpaintner K, Larson MG, Rao VS, O’Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz, D’Agostino RB, Muller JE, Myers RH, Levy D, Tofler GH (1999) Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 19:1142–1147
Feng D, Lindpaintner K, Larson MG, O’Donnell CJ, Lipinska I, Sutherland PA, Mittleman M, Muller JE, D’Agostino RB, Levy D, Tofler GH (2001) Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: the Framingham Heart Study. Circulation 104:140–144
Frederickson BJ, Dong JF, McIntire LV, Lopez JA (1998) Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 92:3684–3693
French DL, Seligsohn U (2000) Platelet glycoprotein IIb/IIIa receptors and Glanzmann’s thrombasthenia. Arterioscler Thromb Vasc Biol 20:607–610
Furihata K, Nugent DJ, Kunicki TJ (2002) Influence of platelet collagen receptor polymorphisms on risk for arterial thrombosis. Arch Pathol Lab Med 126:305–309
Garcia-Ribes M, Gonzalez-Lamuno D, Hernandez-Estefania R, Colman T, Pocovi M, Delgado-Rodriguez M, Garcia-Fuentes M, Revuelta JM (1998) Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis. Thromb Haemost 79:1126–1129
Gardemann A, Humme J, Stricker J, Nguyen QD, Katz N, Philipp M, Tillmanns H, Hehrlein FW, Rau M, Haberbosch W (1998) Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thromb Haemost 80:214–217
George JN, Caen JP, Nurden AT (1990) Glanzmann’s thrombasthenia: the spectrum of clinical disease. Blood 75:1383–1395
Gonzalez Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V (1998) Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 92:2771–2776
Goodall AH, Curzen N, Panesar M, Hurd C, Knight CJ, Ouwehand WH, Fox KM (1999) Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 20:742–747
Hato T, Minamoto Y, Fukuyama T, Fujita S (1997) Polymorphisms of HPA-1 through 6 on platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population. Am J Cardiol 80:1222–1224
Hermann SM, Poirier O, Marques-Vidal P, Evans A, Arveiler D, Luc G, Emmerich J, Cambien F (1997) The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l’Infarctus du Myocarde. Thromb Haemost 77:1179–1181
Ioannidis JP, Ntzani EE, Trikanlinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306–309
Ishida F, Furihata K, Ishida K, Yan J, Kitano K, Kiyosawa K, Furuta S (1995) The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine145. Blood 86:1357–1360
Ishida F, Ito T, Takei M, Shimodaira S, Kitano K, Kiyosawa K (2000) Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ib alpha with human platelet antigen-2 and variable number of tandem repeats polymorphism, and its relationship with coronary artery disease. Br J Haematol 111:1247–1249
Ito T, Ishida F, Shimodaira, Kitano K (1999) Polymorphisms of platelet membrane glycoprotein Ib alpha and plasma von Willebrand factor antigen in coronary artery disease. Int J Hematol 70:47–51
Jacquelin B, Tarantino MD, Kritzik M, Rozenshteyn D, Koziol JA, Nurden AT, Kunicki TJ (2001) Allele-dependent transcriptional regulation of the human integrin alpha2 gene. Blood 97:1721–1726
Jilma-Stohlawetz P, Homoncik M, Jilma B, Knechtelsdorfer M, Unger P, Mannhalter C, Santoso S, Panzer S (2003) Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates. Br J Haematol 120:652–655
Kaiser R, Tremblay PB, Roots I, Brockmoller J (2002) Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem 35:49–56
Kakko S, Elo T, Tapanainen JM, Huikuri HV, Savolainen MJ (2002) Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 32:643–648
Kalb R, Santoso S, Unkelbach K, Kiefel V, Mueller-Eckhardt (1994) Localization of the Br polymorphism on a 144 bp exon of the GPIa gene and its application in platelet DNA typing. Thromb Haemost 71:651–654
Kastrati A, Schomig A, Seyfarth M, Koch W, Elezi S, Bottiger C, Mehilli J, Schomig K, von Beckerath N (1999) PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 99:1005–1010
Kastrati A, Koch W, Gawaz M, Mehilli J, Bottiger C, Schomig K, von Beckerath N, Schomig A (2000) PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol 36:84–89
Kekomäki S, Hamalainen L, Kauppinen-Makelin R, Palomaki H, Kaste M, Kontula K (1999) Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J Cardiovasc Risk 6:13–17
Kenny D, Muckian C, Fitzgerald DJ, Cannon CP, Shields DC (2002) Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients. J Thromb Thrombolysis 13:13–19
Kozak M (1981) Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res 9:5233–5262
Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ (1998) Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood 92:2382–2388
Kroll H, Gardemann A, Fechter A, Haberbosch W, Santoso S (2000) The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction. Thromb Haemost 83:392–396
Kuijpers RW, Faber NM, Cuypers HT, Ouwehand WH, von dem Borne AE (1992a) NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 89:381–384
Kuijpers RW, Ouwehand WH, Bleeker PM, Christie D, von dem Borne AE (1992b) Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ib alpha. Blood 79:283–288
Kunicki TJ (2002) The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 22:14–20
Kunicki TJ, Orchekowski R, Annis D, Honda Y (1993) Variability of integrin alpha 2 beta 1 activity on human platelets. Blood 82:2693–2703
Kunicki TJ, Kritzik M, Annis DS, Nugent DJ (1997) Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence. Blood 89:1939–1943
Lanza F, Kieffer N, Phillips DR, Fitzgerald LA (1990) Characterization of the human platelet glycoprotein IIIa gene. Comparison with the fibronectin receptor beta-subunit gene. J Biol Chem 265:18098–18103
Laule M, Cascorbi I, Stangl V, Bielecke C, Wernecke KD, Mrozikiewicz PM, Felix SB, Roots I, Baumann G, Stangl K (1999) A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study. Lancet 253:708–712
Li CQ, Garner SF, Davies J, Smethurst PA, Wardell MR, Ouwehand WH (2000) Threonine-145/methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbalpha express HPA-2 epitopes and show equal binding of von Willebrand factor. Blood 95:205–211
Lopez JA, Dong JF (1997) Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol 4:323–329
Lopez JA, Ludwig EH, McCarthy BJ (1992) Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 267:10055–10061
Lopez JA, Andrews RK, Afshar Kharghan V, Berndt MC (1998) Bernard-Soulier syndrome. Blood 91:4397–4418
Mamotte CD, van Bockxmeer FM, Taylor RR (1998) PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol 82:13–16
Marian AJ, Brugada R, Kleiman NS (1996) Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction. N Engl J Med 335:1071–1072; discussion 1073–1074
Mazzucato M, Pradella P, de Angelis V, Steffan A, de Marco L (1996) Frequency and functional relevance of genetic threonine145/methionine145 dimorphism in platelet glycoprotein Ib alpha in an Italian population. Transfusion 36:891–894
Meiklejohn DJ, Vickers MA, Morrison ER, Dijkhuisen R, Moore I, Urbaniak SJ, Greaves M (2001) In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib. Br J Haematol 112:621–631
Meisel C, Laule M, Cascorbi I, Herrmann A, Stangl V, Roots I, Stangl K (2000a) The platelet glycoprotein Ia C807T polymorphism as risk factor for coronary catheter interventions. Blood 96:2002–2003
Meisel C, Roots I, Cascorbi I, Brinkmann U, Brockmöller J (2000b) How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport. Clin Chem Lab Med 38:869–876
Meisel C, Afshar Kharghan V, Cascorbi I, Laule M, Stangl V, Felix SB, Baumann, Lopez JA, Roots I, Stangl K (2001) Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol 38:1023–1027
Meisel C, Gerloff T, Kirchheiner J, Mrozikiewicz PM, Niewinski P, Brockmöller J, Roots I (2003) Implications of pharmacogenetics for individualising drug treatment and for study design. J Mol Med 81:154–167
Mercier B, Munier S, Berault V, Mansourati J, Blanc JJ, Ferec C (2000) Myocardial infarction: absence of association with VNTR polymorphism of GP Ibalpha. Thromb Haemost 84:921–922
Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L, Hamlington J, Barnard MR, Kickler T, Christie DJ, Kundu S, Bray PF (2000) Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 101:1013–1018
Mikkelsson J, Perola M, Laippala P, Savolainen V, Pajarinen J, Lalu K, Penttila A, Karhunen PJ (1999) Glycoprotein IIIa PlA polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscl Thromb Vasc Biol 19:2573–2578
Mikkelson J, Perola M, Penttila A, Karhunen PJ (2001) Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death. Circulation 104:876–880
Miller JL (1996) Platelet-type von Willebrand disease. Thromb Haemost 75:865–869
Morita H, Kurihara H, Imai Y, Sugiyama T, Hamada C, Sakai E, Mori M, Nagai R (2001) Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and myocardial infarction in Japanese. An approach entailing melting curve analysis with specific fluorescent hybridization probes. Thromb Haemost 85:226–230
Moroi M, Jung SM, Yoshida N (1984) Genetic polymorphism of platelet glycoprotein Ib. Blood 64:622–629
Moshfegh K, Wuillemin WA, Redondo M, Lammle B, Beer JH, Liechti-Gallati S, Meyer BJ (1999) Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353:351–354
Murata M, Furihata K, Ishida F, Russell SR, Ware J, Ruggeri ZM (1992) Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ib alpha involved in platelet transfusion refractoriness. Blood 79:3086–3090
Murata M, Matsubara Y, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y (1997) Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 96:3281–3286
Newman PJ (1997) Platelet alloantigens: cardiovascular as well as immunological risk factors? Lancet 349:370–371
Newman PJ, Derbes RS, Aster RH (1989) The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 83:1778–1781
Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ (1985) Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318:470–472
Nieuwenhuis HK, Sakariassen KS, Houdijk WP, Nievelstein PF, Sixma JJ (1986) Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood 68:692–695
Nurden AT, Nurden P (2001) Inherited defects of platelet function. Rev Clin Exp Hematol 5:314–334; quiz 431
O’Connor FF, Shields DC, Fitzgerald A, Cannon CP, Braunwald E, Fitzgerald DJ (2001) Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes. Blood 98:3256–3260
Osborn SV, Hampton KK, Smillie D, Channer KS, Daly ME (1996) Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet 348:1309–1310
Phillips DR, Charo IF, Parise LV, Fitzgerald LA (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831–843
Prandini MH, Denarier E, Frachet P, Uzan G, Marguerie G (1988) Isolation of the human platelet glycoprotein IIb gene and characterization of the 5’ flanking region. Biochem Biophys Res Commun 156:595–601
Reiner AP, Kumar PN, Schwartz SM, Longstreth WT Jr, Pearce RM, Rosendaal FR, Psaty BM, Siscovick DS (2000) Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31:1628–1633
Reiner AP, Siscovick DS, Rosendaal FR (2001) Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies. Rev Clin Exp Hematol 5:262–287; discussion 311–262
Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K (1997) PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349:385–388
Roest M, Banga JD, Grobbee DE, de Groot PG, Sixma JJ (2000) Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in high-risk women. Circulation 102:1645–1650
Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA (1999) The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 190:803–814
Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126
Ruan J, Peyruchaud O, Nurden A, Bourre F (1998) Linkage of four polymorphisms on the alphaIIb gene. Br J Haematol 102:622–625
Samani NJ, Lodwick D (1997) Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res 33:693–697
Santoro SA (1999) Platelet surface collagen receptor polymorphisms: variable receptor expression and thrombotic/hemorrhagic risk. Blood 93:3575–3577
Santoso S, Kalb R, Walka M, Kiefel V, Mueller-Eckhardt C, Newman PJ (1993) The human platelet alloantigens Br(a) and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2). J Clin Invest 92:2427–2432
Santoso S, Amrhein J, Hofmann HA, Sachs UJ, Walka MM, Kroll H, Kiefel V (1999a) A point mutation Thr(799)Met on the alpha(2) integrin leads to the formation of new human platelet alloantigen Sit(a) and affects collagen-induced aggregation. Blood 94:4103–4111
Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A (1999b) Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in young patients. Blood 93:2449–2453
Santoso S, Zimmermann P, Sachs UJ, Gardemann A (2002) The impact of the Kozak sequence polymorphism of the glycoprotein Ib alpha gene on the risk and extent of coronary heart disease. Thromb Haemost 87:345–346
Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289–297
Scaglione L, Bergerone S, Gaschino G, Imazio M, Maccagnani A, Gambino R, Cassader M, Di Leo M, Macchia G, Brusca A, Pagano G, Cavallo-Perin (1998) Lack of relationship between the P1A1/P1A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction. Eur J Clin Invest 28:385–388
Shattil SJ, Kashiwagi H, Pampori N (1998) Integrin signaling: the platelet paradigm. Blood 91:2645–2657
Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA (2000) Platelet glycoprotein Ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 192:193–204
Sonoda A, Murata M, Ito D, Tanahashi N, Ohta A, Tada Y, Takeshita E, Yoshida T, Saito I, Yamamoto M, Ikeda Y, Fukuuchi Y, Watanabe K (2000) Association between platelet glycoprotein Ibalpha genotype and ischemic cerebrovascular disease. Stroke 31:493–497
Sonoda A, Murata M, Ikeda Y, Fukuuchi Y, Watanabe K (2001) Stroke and platelet glycoprotein Ibalpha polymorphisms. Thromb Haemost 85:573–574
Sperr WR, Huber K, Roden M, Janisiw M, Lang T, Graf S, Maurer G, Mayr WR, Panzer S (1998) Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans. Thromb Res 90:117–123
Streifler JY, Rosenberg N, Chetrit A, Eskaraev R, Sela BA, Dardik R, Zivelin A, Ravid B, Davidson J, Seligsohn U, Inbal A (2001) Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 32:2753–2758
Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W (2000) Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110:965–967
Tanaka S, Ohnoki S, Shibata H, Okubo Y, Yamaguchi H, Shibata Y (1996) Gene frequencies of human platelet antigens on glycoprotein IIIa in Japanese. Transfusion 36:813–817
Theodoropoulos I, Christopoulos C, Metcalfe P, Dimitriadou E, Economopoulos P, Loucopoulos D (2001) The effect of human platelet alloantigen polymorphisms on the in vitro responsiveness to adrenaline and collagen. Br J Haematol 114:387–393
Thornton MA, Poncz M, Korostishevsky M, Yakobson E, Usher S, Seligsohn U, Peretz H (1999) The human platelet alphaIIb gene is not closely linked to its integrin partner beta3. Blood 94:2039–2047
Undas A, Sanak M, Musial J, Szczeklik A (1999) Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet 353:982–983
Undas A, Brummel K, Musial J, Mann KG, Szczeklik A (2001) Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 104:2666–2672
Van Goor ML, Gomez Garcia E, Brouwers GJ, Leebeek FW, Koudstaal PJ, Dippel DW (2002) PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke. Thromb Res 108:63–65
Von Beckerath N, Koch W, Mehilli J, Böttiger C, Schömig A, Kastrati A (2000) Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood 95:3297–3301
Von Beckerath N, Koch W, Mehilli J, Bottiger C, Braun S, Schomig A, Kastrati A (2001) Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting. Atherosclerosis 156:463–468
Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, Goldschmidt-Clermont PJ, Croft JB, Brown VK, Stern BJ, Feeser BR, Buchholz DW, Earley CJl, Macko RF, McCarter RJ, Sloan MA, Stolley PD, Wityk RJ, Wozniak MA, Price TR, Kittner SJ (1998) Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke 29:581–585
Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM (1997) Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 350:1217–1219
Walter DH, Schachinger V, Elsner M, Mach S, Dimmeler S, Auch-Schwelk W, Zeiher AM (2001) Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene. Eur Heart J 22:587–595
Ware J (1998) Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb Haemost 79:466–478
Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ (1996) A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334:1090–1094
Wheeler GL, Braden GA, Bray PF, Marciniak SJ, Mascelli MA, Sane DC (2002) Reduced inhibition by abciximab in platelets with the PlA2 polymorphism. Am Heart J 143:76–82
Zhu MM, Weedon J, Clark LT (2000) Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction. Am J Cardiol 86:1000–1005
Zotz RB, Winkelmann BR, Nauck M, Giers G, Maruhn-Debowski B, Marz W, Scharf RE (1998) Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 79:731–735
Acknowledgements
This work was supported by the German Ministry of Education, and Research “Berlin Center for Genome Based Bioinformatics” grant 031U209B the “Lead Project Partnership: Pharmacogenetic Diagnostics” grant 01 GG 9845/5, and a grant from the US National Institutes of Health (Grant RO1 HL65205).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meisel, C., López, J.A. & Stangl, K. Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn-Schmiedeberg's Arch Pharmacol 369, 38–54 (2004). https://doi.org/10.1007/s00210-003-0828-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-003-0828-y